OxRML/AgentSLR huggingface dataset:
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 27
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 4
Upper bound: 57.1
Bounds: 4 - 57.1
CFR/IFR numerator: 181
CFR/IFR denominator: 668
CFR/IFR method: Naive
Epidemic phase: Unspecified
Disaggregated by: Age, Level of exposure, Other, Sex
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 668
Country: Taiwan,  China
Study period: 14 Mar 03 2003 to 30 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 668
Country: Taiwan,  China
Study period: 14 Mar 03 2003 to 30 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 21.1
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 73
CFR/IFR denominator: 346
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 346
Country: Taiwan,  China
Study period: 14 Mar 03 2003 to 30 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 10.7
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 37
CFR/IFR denominator: 346
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 346
Country: Taiwan,  China
Study period: 14 Mar 03 2003 to 30 Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 4
Unit: Days
Value type: Median
Uncertainty type: Range [Sample]
Uncertainty lower value: 3
Uncertainty upper value: 6
Combined uncertainty: 3 - 6 (Range [Sample])
Epidemic phase: Unspecified
Population group: Mixed groups
Sample type: Hospital based
Sex: Both
Minimum age: 14
Maximum age: 82
Sample size: 32
Country: Taiwan,  China
Location: Ho-Ping Hospital
Study period: 17 Apr 04 2003 to 26 Apr 04 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 27
Unit: Days
Value type: Median
Uncertainty type: Unspecified
Uncertainty lower value: 12
Uncertainty upper value: 48
Combined uncertainty: 12 - 48 (Unspecified)
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 52
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - admission to care>death
Parameter value: 17
Unit: Days
Value type: Median
Uncertainty type: Unspecified
Uncertainty lower value: 1
Uncertainty upper value: 38
Combined uncertainty: 1 - 38 (Unspecified)
Epidemic phase: Unspecified
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Sample size: 25
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.6
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 52
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 60
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Naive
Epidemic phase: Unspecified
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Sample size: 25
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 92
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 46
CFR/IFR denominator: 50
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 50
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 42
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 8
CFR/IFR denominator: 19
Epidemic phase: Unspecified
Population group: Other
Sample type: Hospital based
Sex: Unspecified
Sample size: 19
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 77
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age
Risk factor outcome: Serology
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Country: Hong Kong SAR,  China
Location: Kwong Wah Hospital
Study period: 22 Feb 02 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 5.8
Unit: Days
Value type: Mean
Uncertainty single value: 5.4 (Standard deviation (Sd) [Sample])
Combined uncertainty: 5.4 (Standard deviation (Sd) [Sample])
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 167
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 10 Mar 03 2003 to 5 Jun 06 2003
Other delay start: Symptom Onset/Fever
Other delay end: Diagnosis by Chest X-ray
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - Unspecified
Parameter value: 96.6
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR numerator: 171
CFR/IFR denominator: 177
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 177
Country: Hong Kong SAR,  China
Location: Prince of Wales Hospital
Study period: 10 Mar 03 2003 to 5 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 6.55
Unit: Percentage (%)
Value type: Unspecified
Lower bound: 3.84
Upper bound: 8
Bounds: 3.84 - 8
CFR/IFR numerator: 349
CFR/IFR denominator: 5327
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 5327
Country: China
Location: Guangdong, Shanxi, Hebei, Beijing, Tianjin
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Sample size: 5327
Country: China
Location: Guangdong, Shanxi, Hebei, Beijing, Tianjin
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 3.84
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Guangdong
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 5.36
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Shanxi
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 5.58
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Hebei
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 7.66
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Beijing
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 8
Unit: Percentage (%)
Value type: Unspecified
CFR/IFR method: Adjusted
Epidemic phase: Unspecified
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: China
Location: Tianjin
Study period:  Apr 04 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Occupation;Other
Risk factor outcome: Incubation Period
Risk factor occupation: Healthcare
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Sample size: 317
Country: Canada, Hong Kong SAR,  China
Location: Toronto, Hong Kong
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Unspecified
Risk factor: Age;Sex
Risk factor outcome: Incubation Period
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Sample size: 317
Country: Canada, Hong Kong SAR,  China
Location: Toronto, Hong Kong
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - incubation period
Parameter value: 5.1
Unit: Days
Value type: Mean
Lower bound: 4.4
Upper bound: 5.6
Bounds: 4.4 - 5.6
Distribution type: Normal-Log
Distribution parameter 1: 5.1 (Mean)
Distribution parameter 2: 18.3 (Variance)
Epidemic phase: Unspecified
Disaggregated by: Region
Population group: Persons under investigation
Sample type: Population based
Sex: Both
Sample size: 317
Country: Canada, Hong Kong SAR,  China
Location: Toronto, Hong Kong
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 17.2
Unit: Percentage (%)
Value type: Mean
CFR/IFR numerator: 302
CFR/IFR denominator: 1755
CFR/IFR method: Naive
Epidemic phase: Post outbreak
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Country: Hong Kong SAR,  China
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Unit: No units
Value type: Unspecified
Upper bound: 12.2
Reproduction number method: Branching process
Reproduction number pathway: Human-human
Disaggregated by: Time
Population group: Persons under investigation
Sample type: Population based
Sex: Unspecified
Country: Hong Kong SAR,  China
Study period:  Feb 02 2003 to  Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - infectious period
Parameter value: 9.3
Unit: Days
Value type: Mean
Uncertainty type: 95% CrI
Uncertainty lower value: 8.6
Uncertainty upper value: 9.9
Uncertainty single value: 2.3 (Standard Deviation)
Combined uncertainty: 8.6 - 9.9 (95% CrI)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 1467
Country: Hong Kong SAR,  China
Study period:  Mar 03 2003 to  Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Reproduction number
Parameter type: Reproduction number (Effective, Re)
Reproduction number method: Compartmental model
Reproduction number pathway: Human-human
Population group: Persons under investigation
Sample type: Hospital based
Sex: Unspecified
Sample size: 1467
Country: China
Location: Hong Kong
Study period:  Mar 03 2003 to  Jul 07 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 35.2
Unit: Days
Value type: Mean
Uncertainty single value: 15.4 (Standard Deviation)
Combined uncertainty: 15.4 (Standard Deviation)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Hong Kong SAR,  China
Location: United Christian Hospital
Study period: 24 Mar 03 2003 to 4 May 05 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Discharge from Care/Hospital
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 30
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 81
Combined uncertainty: 2 - 81 (Range)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Hong Kong SAR,  China
Study period: 24 Mar 03 2003 to 4 May 05 2003
Other delay start: Admission to Care/Hospitalisation
Other delay end: Negative RT-PCR test
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 13
Unit: Days
Value type: Median
Uncertainty type: Range
Uncertainty lower value: 2
Uncertainty upper value: 60
Combined uncertainty: 2 - 60 (Range)
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Hong Kong SAR,  China
Study period: 24 Mar 03 2003 to 4 May 05 2003
Other delay start: Discharge from Care/Hospital
Other delay end: Negative RT-PCR test
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Other
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Hong Kong SAR,  China
Study period: 24 Mar 03 2003 to 4 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age;Cormobidity;Other;Sex
Risk factor outcome: Other
Risk factor significance: Not significant
Risk factor adjustment: Unspecified
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Sample size: 45
Country: Hong Kong SAR,  China
Study period: 24 Mar 03 2003 to 4 May 05 2003
Pathogen: SARS-CoV
Parameter class: Seroprevalence
Parameter type: Seroprevalence - IgG
Parameter value: 0
Unit: Percentage (%)
CFR/IFR numerator: 0
CFR/IFR denominator: 674
Epidemic phase: Unspecified
Population group: Healthcare workers
Sample type: Hospital based
Sex: Both
Minimum age: 20
Maximum age: 60
Sample size: 674
Country: Hong Kong SAR,  China
Location: Hong Kong
Study period:  Mar 03 2003 to  May 05 2003
Pathogen: SARS-CoV
Parameter class: Other transmission parameters
Parameter type: Secondary attack rate
Parameter value: 8.8
Unit: Percentage (%)
Disaggregated by: Other
Population group: Household contacts of survivors
Sample type: Household based
Sex: Unspecified
Sample size: 697
Country: Hong Kong SAR,  China
Study period: 28 Feb 02 2003 to 8 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3
Unit: Days
Value type: Mean
Uncertainty single value: 3.1 (Standard Deviation)
Combined uncertainty: 3.1 (Standard Deviation)
Disaggregated by: Other
Population group: Healthcare workers
Sample type: Hospital based
Sex: Unspecified
Sample size: 268
Country: Hong Kong SAR,  China
Study period: 28 Feb 02 2003 to 8 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Age
Risk factor outcome: Serology
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Unspecified
Population group: General population
Sample type: Hospital based
Sex: Unspecified
Sample size: 375
Country: Hong Kong SAR,  China
Study period: 4 Mar 03 2003 to 6 Jun 06 2003
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 2.3
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 6.8
Combined uncertainty: 0 - 6.8 (95% CI)
CFR/IFR numerator: 1
CFR/IFR denominator: 44
Distribution type: Bernoulli
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 15
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 15.6
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 9.8
Uncertainty upper value: 22.8
Combined uncertainty: 9.8 - 22.8 (95% CI)
CFR/IFR denominator: 634
Distribution type: Bernoulli
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Sample size: 634
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 12.9
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 0
Uncertainty upper value: 25.8
Combined uncertainty: 0 - 25.8 (95% CI)
CFR/IFR denominator: 31
Distribution type: Bernoulli
Population group: Persons under investigation
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 84
Sample size: 31
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 14
Unit: Percentage (%)
Value type: Mean
Uncertainty type: 95% CI
Uncertainty lower value: 5.2
Uncertainty upper value: 26.3
Combined uncertainty: 5.2 - 26.3 (95% CI)
CFR/IFR denominator: 343
Distribution type: Bernoulli
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 84
Sample size: 343
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Death
Risk factor occupation: Unspecified
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Sample size: 678
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Risk factor: Other
Risk factor outcome: Death
Risk factor occupation: Unspecified
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 84
Sample size: 374
Country: Hong Kong SAR,  China
Study period: 16 Apr 04 2003 to
Pathogen: SARS-CoV
Parameter class: Severity
Parameter type: Severity - case fatality rate (CFR)
Parameter value: 15.7
Unit: Percentage (%)
CFR/IFR numerator: 18
CFR/IFR denominator: 115
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 115
Country: Hong Kong SAR,  China
Study period: 9 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 115
Country: Hong Kong SAR,  China
Study period: 9 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 115
Country: Hong Kong SAR,  China
Study period: 9 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Mid outbreak
Risk factor: Age;Other
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 115
Country: Hong Kong SAR,  China
Study period: 9 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - symptom onset>admission to care
Parameter value: 3.6
Unit: Days
Value type: Mean
Uncertainty single value: 2.4 (Standard deviation (Sd) [Sample])
Combined uncertainty: 2.4 (Standard deviation (Sd) [Sample])
Epidemic phase: Mid outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Sample size: 115
Country: Hong Kong SAR,  China
Study period: 9 Mar 03 2003 to 31 May 05 2003
Pathogen: SARS-CoV
Parameter class: Human delay
Parameter type: Human delay - other human delay (go to section)
Parameter value: 12.7
Unit: Days
Uncertainty single value: 6.3 (Standard deviation (Sd) [Sample])
Combined uncertainty: 6.3 (Standard deviation (Sd) [Sample])
Epidemic phase: Post outbreak
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Other delay start: Symptom Onset/Fever
Other delay end: Admission to Critical Care/ICU
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Age;Close contact;Cormobidity;Other;Sex
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Other
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Not adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Age;Close contact;Other;Sex
Risk factor outcome: Death
Risk factor significance: Significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003
Pathogen: SARS-CoV
Parameter class: Risk factors
Parameter type: Risk factors
Epidemic phase: Post outbreak
Risk factor: Close contact;Other;Sex
Risk factor outcome: Death
Risk factor significance: Not significant
Risk factor adjustment: Adjusted
Population group: General population
Sample type: Hospital based
Sex: Both
Minimum age: 15
Maximum age: 74
Sample size: 1312
Country: Hong Kong SAR,  China
Study period:   2003 to   2003